The North America continuous glucose monitoring (CGM) market is experiencing impressive growth, driven by the rising prevalence of diabetes and advancements in real-time glucose monitoring technologies. In 2024, the market stood at USD 6.56 billion and is projected to grow at a CAGR of 14.50%, reaching approximately USD 25.41 billion by 2034. To explore detailed market forecasts, drivers, and...